Nextbiotics was founded in 2017 with the goal of leveraging cutting edge synthetic biology tools and bacteriophage technology to provide unique solutions to the antibiotic resistance crisis.

Our Team

Our team brings a unique combination of genome engineering, phage biology, pharma and bioinformatics experience.
Jorge Bardales
Co-founder & CEO
PhD, Biophysics, 
UC Berkeley
Maricel Saenz
BCom, Finance, 
UBC  Strategy, 
Management Consultant
Matthew Youngblut
Bacteriophage Expert
PhD, Chemistry,
Post Doc Research, 
UC Berkeley

Carlos Llanos
Scientist, Bacteriophages
Andrew Favor
Scientist, Bioinformatics
BS, Chemical Biology, 
UC Berkeley

Our Advisors

We have assembled the best scientific advisory board in our field, with the world leaders in phage biology and commercial expertise.
Timothy K Lu
Phage Engineering Leader & Entrepreneur
Co- Founder
Senti Bioscience,
Eligo Bioscience, BiomX, Sample 6,
Associate Professor, MIT
Kim Seed
Phage Lab, 
UC Berkeley
Director of Seed Lab,
UC Berkeley
Burroughs Wellcome Fund and Chan Zuckerberg
Biohub Investigator
Steffanie Strathdee
1st documented case of phage use in USA
Founder of IPATH
Author: Perfect Predator
Associate Dean of Global Health Sciences, UCSD

Paul Turner
Phage Lab, 
Evolutionary genetics & bacteriophages.
Treated 10 patients with phages for AMR infections
Mario Arguello
Commercial Avian Sciences
Boehringer Ingelheim



2945 Webster Street,
Oakland, CA, 94609, USA.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.